ClinVar Miner

Submissions for variant NM_000155.4(GALT):c.983G>A (p.Arg328His) (rs111033802)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Integrated Genetics/Laboratory Corporation of America RCV000022254 SCV000919406 likely pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2018-11-26 criteria provided, single submitter clinical testing Variant summary: GALT c.983G>A (p.Arg328His) results in a non-conservative amino acid change located in the Galactose-1-phosphate uridyl transferase, C-terminal domain of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function, including one computational study that considers the Arg328 H-bond with Arg-51 essential for protein function (Facchiano_2009). The variant allele was found at a frequency of 4.1e-06 in 246246 control chromosomes (gnomAD). The variant, c.983G>A, has been reported in the literature in individuals affected with Galactosemia, including a homozygote (Ozgul_2013, Elsas_1998). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, with one lab calling it pathogenic in 2012. A different variant affecting the same codon, c.982C>T (p.Arg328Cys), was classified as likely pathogenic internally, suggesting this codon could play an important role in protein function. Based on the evidence outlined above, the variant was classified as likely pathogenic.
Baylor Genetics RCV000022254 SCV001163251 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase criteria provided, single submitter clinical testing
Research and Development, ARUP Laboratories RCV000022254 SCV000042938 pathogenic Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase 2012-12-04 no assertion criteria provided clinical testing Converted during submission to Pathogenic.
Natera, Inc. RCV001271248 SCV001452292 likely pathogenic Galactosemia 2020-09-16 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.